Click on image to view larger version.

Figure 1 Rates of all-cause mortality (D), myocardial infarction (MI) , and severe recurrent ischemia leading to urgent revascularization (UR) through 14 days among patients randomized to unfractionated heparin in Thrombolysis In Myocardial Infarction (TIMI) 11B trial, with patients stratified by the TIMI risk score. NSTEMI = non–ST-segment elevation myocardial infarction; % Popl’n = percent of overall trial population with that TIMI risk score; UA = unstable angina. Adapted from Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non–ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835–42.